These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10401594)

  • 1. Proton magnetic resonance spectroscopy in schizophrenia.
    Bertolino A; Weinberger DR
    Eur J Radiol; 1999 May; 30(2):132-41. PubMed ID: 10401594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings.
    Poels EM; Kegeles LS; Kantrowitz JT; Javitt DC; Lieberman JA; Abi-Dargham A; Girgis RR
    Schizophr Res; 2014 Feb; 152(2-3):325-32. PubMed ID: 24418122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in neuroimaging in schizophrenia: magnetic resonance spectroscopy].
    Galińska B; Szulc A; Walecki J; Kubas B; Tarasów E
    Pol Merkur Lekarski; 2003 Sep; 15(87):278-80. PubMed ID: 14679857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study.
    Goto N; Yoshimura R; Moriya J; Kakeda S; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Hayashi K; Oonari N; Korogi Y; Nakamura J
    Schizophr Res; 2009 Jul; 112(1-3):192-3. PubMed ID: 19464152
    [No Abstract]   [Full Text] [Related]  

  • 6. [Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations].
    Wobrock T; Scherk H; Falkai P
    Radiologe; 2005 Feb; 45(2):124-30, 132-6. PubMed ID: 15645203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorus magnetic resonance spectroscopy: its utility in examining the membrane hypothesis of schizophrenia.
    Reddy R; Keshavan MS
    Prostaglandins Leukot Essent Fatty Acids; 2003 Dec; 69(6):401-5. PubMed ID: 14623493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton MRS and MRSI of the brain without water suppression.
    Dong Z
    Prog Nucl Magn Reson Spectrosc; 2015 Apr; 86-87():65-79. PubMed ID: 25919199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Spectroscopy for Psychiatry: Progress in the Last Decade.
    Port JD
    Neuroimaging Clin N Am; 2020 Feb; 30(1):25-33. PubMed ID: 31759569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.
    Abbott C; Bustillo J
    Curr Opin Psychiatry; 2006 Mar; 19(2):135-9. PubMed ID: 16612192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy.
    Kegeles LS; Humaran TJ; Mann JJ
    Biol Psychiatry; 1998 Sep; 44(6):382-98. PubMed ID: 9777167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies.
    Schwerk A; Alves FD; Pouwels PJ; van Amelsvoort T
    J Neurochem; 2014 Jan; 128(1):1-87. PubMed ID: 23937509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part I.
    Stanley JA; Pettegrew JW; Keshavan MS
    Biol Psychiatry; 2000 Sep; 48(5):357-68. PubMed ID: 10978719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A; Galinska B; Tarasow E; Waszkiewicz N; Konarzewska B; Poplawska R; Bibulowicz D; Simonienko K; Walecki J
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy changes after antipsychotic treatment.
    Szulc A; Galinska-Skok B; Waszkiewicz N; Bibulowicz D; Konarzewska B; Tarasow E
    Curr Med Chem; 2013; 20(3):414-27. PubMed ID: 23157634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: a combined MRI and 1H-MRS study.
    Klär AA; Ballmaier M; Leopold K; Häke I; Schaefer M; Brühl R; Schubert F; Gallinat J
    Neuroimage; 2010 Oct; 53(1):51-7. PubMed ID: 20541020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [To Test Glutamate Hypothesis for Schizophrenia Utilizing Proton Magnetic Resonance Spectroscopy].
    Tsugawa S; Nakajima SL
    Brain Nerve; 2017 Sep; 69(9):1035-1040. PubMed ID: 28900066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance spectroscopy in schizophrenia].
    Delamillieure P; Constans JM; Fernandez J; Dollfus S
    Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?
    Vion-Dury J; Meyerhoff DJ; Cozzone PJ; Weiner MW
    J Neurol; 1994 May; 241(6):354-71. PubMed ID: 7931430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo magnetic resonance spectroscopy. Applications in psychiatry.
    Maier M
    Br J Psychiatry; 1995 Sep; 167(3):299-306. PubMed ID: 7496637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.